NTAP research initiatives are dedicated to filling critical gaps in the pipeline to developing therapies for patients with cutaneous neurofibromas (cNFs). Informed by discussions with patients, scientists, clinicians, industry leaders, investors and government collaborators, NTAP has identified critical gaps in knowledge that limit the development of therapeutics for cNFs. Research initiatives recruit investigators with innovative ideas to address these gaps as quickly and robustly as technology will allow.

NTAP-directed grants target specific research questions where providing funding or other support can accelerate cNF drug discovery and remove obstacles to clinical development. In addition, NTAP invites proposals from any investigator (regardless of their location or primary research focus) who have independent research projects (open proposals) designed to accelerate the development of effective treatments for cNFs.

Current NTAP initiatives include: